ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 117 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $408,000 | -40.5% | 15,050 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $686,000 | -39.8% | 15,050 | +10.3% | 0.00% | -33.3% |
| Q4 2021 | $1,139,000 | +39.2% | 13,650 | +2.6% | 0.00% | +50.0% |
| Q3 2021 | $818,000 | +15.7% | 13,300 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $707,000 | +31.9% | 13,300 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $536,000 | -26.1% | 13,300 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $725,000 | – | 13,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mayo Clinic | 187,143 | $765,415 | 25.27% |
| Decheng Capital LLC | 3,070,442 | $12,558,107 | 3.85% |
| MPM BioImpact LLC | 1,450,000 | $5,930,500 | 0.92% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 961,486 | $3,932,478 | 0.80% |
| Eventide Asset Management | 8,547,896 | $34,960,895 | 0.60% |
| 5AM Venture Management, LLC | 490,000 | $2,004,100 | 0.45% |
| Matrix Capital Management Company, LP | 13,959,973 | $57,096,290 | 0.44% |
| Values First Advisors, Inc. | 74,925 | $306,443 | 0.18% |
| Boxer Capital, LLC | 450,000 | $1,840,500 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 255,201 | $1,044 | 0.07% |